Cibc World Markets Corp Invests $259,000 in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
Cibc World Markets Corp purchased a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 27,460 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. A number of other hedge funds have also bought and sold shares of FOLD. HealthInvest Partners AB […]
Cibc World Markets Corp purchased a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 27,460 shares of the biopharmaceutical company’s stock, valued at approximately $259,000. A number of other hedge funds have also bought and sold shares of FOLD. HealthInvest Partners AB […]
